ARROWHEAD PHARMACEUTICALS, INC. ARWR
CIK 0000879407
Form 4 transactions dated Nov 1, 2023 to Nov 9, 2026, as reported to the SEC.
Insider purchases & sales
- Purchased
- $82.99K
- Sold
- $59.65M
Nov 1, 2023 – Aug 20, 2026
Available records · partial months are marked ·
| Date | Insider | Activity | Trade value (USD) | % of prior holding | |
|---|---|---|---|---|---|
| Aug 18, 2026 | PERRY MICHAEL S Director | Sale | $1.01M 11,600 shares sold | 9.43% sold Direct holding | ▾ |
| Aug 18, 2026 | OLUKOTUN ADEOYE Y Director | Sale | $173.92K 2,000 shares sold | 5.95% sold Direct holding | ▾ |
| May 12, 2026 | Lu Hongbo Director | Sale10b5-1 footnote | $228.33K 2,970 shares sold | 5.40% sold Direct holding | ▾ |
| Apr 23, 2026 | Hamilton James C Chief Medical Officer | Sale10b5-1 footnote | $750.00K 10,000 shares sold | 4.22% sold Direct holding | ▾ |
| Apr 22, 2026 | Apel Daniel Joseph Chief Financial Officer | Sale10b5-1 footnote | $934.29K 13,095 shares sold | 7.44% sold Direct holding | ▾ |
| Mar 5, 2026 | Hamilton James C Chief Medical Officer | Sale10b5-1 footnote | $641.90K 10,000 shares sold | 4.05% sold Direct holding | ▾ |
| Jan 5, 2026 | Hamilton James C Chief Medical Officer | Sale10b5-1 footnote | $2.53M 40,164 shares sold | 18.93% sold Direct holding | ▾ |
| Jan 5, 2026 | O'Brien Patrick COO | Sale10b5-1 footnote | $3.12M 49,493 shares sold | 9.44% sold Direct holding | ▾ |
| Jan 2, 2026 | Anzalone Christopher Richard Chief Executive Officer · Director | Sale10b5-1 footnote | $871.70K 13,187 shares sold | 0.35% sold Direct holding | ▾ |
Showing 9 / 9 record groups in 2026. The complete set is available through the API.
Follow the people behind the trades.
Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.
- Download CSV
- Earlier filings
- Advanced screening & filtering
- API & AI access
+ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 9 of 9 purchase / sale groups and 5 of 5 other groups; the totals and the monthly series cover the whole window.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.
MCP https://api.akkrudata.ai/mcp
akkru_insider_transactions
{"action":"list","ticker":"ARWR","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP / CLI documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.